# General Hospital Corporation (The) – FDA Inspection, May 23, 2024

Source: https://www.keypedia.com/records/fda_inspections/general-hospital-corporation-the/e738af6e-d8d5-413b-8b09-d618e307f7df
Source feed: FDA_Inspections

> FDA inspection 1241625 of General Hospital Corporation (The), May 23, 2024. Classification: No Action Indicated (NAI). 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1241625
- Company Name: General Hospital Corporation (The)
- Inspection Date: 2024-05-23
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1110333 - 2019-10-23
- [FDA Inspection 1094535 - 2019-06-17](https://www.keypedia.com/records/fda_inspections/general-hospital-corporation-the/db11e25c-8bc5-4298-a47d-fb1f779c42e4)
- FDA Inspection 1042063 - 2018-01-31
- FDA Inspection 999897 - 2017-01-24
- [FDA Inspection 992257 - 2016-10-20](https://www.keypedia.com/records/fda_inspections/general-hospital-corporation-the/541ecc6a-226f-45ea-83a4-06f4f00fdb2c)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/jonah-s-ufferfilge/6bcd2028-9aca-4704-bd7b-c835874fad9d)
- Lorayne A. Mcguinness

Company: https://www.keypedia.com/companies/general-hospital-corporation-the/469c1e4a-068e-47c6-82e0-601bd44c6c57

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d